Searcharxiv⌕ Search

arXiv subjects

Ivan Poddiakov

Publications and source records attributed to Ivan Poddiakov.

2 recordsLinked to original sources

Breath-Dx: A Time Series Classification Benchmark for Disease Screening with eNose

Electronic nose (eNose) technology offers a portable, non-invasive route for disease screening via exhaled breath analysis. However, progress in the field is hindered by the lack of systematic benchmarks that compare machine learning methods under realistic conditions, particularly sensor drift, a known but rarely quantified failure mode. Most existing studies rely on small, private datasets with inconsistent protocols, rendering results non-comparable and slowing progress. We introduce Breath-Dx, the first comprehensive benchmark of time series classification methods for breath-based disease screening. Our work leverages the Scent of Health (S-OH) dataset, the largest public clinical eNose collection to date, comprising 1,234 patients across nine diagnostic groups, each providing a 17-channel multivariate time series with explicit temporal train/test splits that account for sensor drift. We systematically evaluate 10 methods spanning four families: feature-based tabular learners, convolution-based models, graph-based, and time series architectures. All methods degrade significantly under temporal validation (0.05-0.12 AUC drop compared to random cross-validation), confirming that drift embeds a strong temporal signal. Under this realistic evaluation, the best methods achieve ROC AUC of 0.74-0.76 for some lung conditions, though others remain near chance. Recurrent architectures show the most consistent performance across diseases, while specialized time series methods achieve the highest peak results. Demographic confounders matter: breath signals provide independent diagnostic value for some conditions but add little beyond age for others. We release the S-OH dataset, all temporal splits, evaluation protocols, and code to enable reproducible research and accelerate progress in clinical breathomics.

cs.LG↗

MADD: Multi-Agent Drug Discovery Orchestra

Hit identification is a central challenge in early drug discovery, traditionally requiring substantial experimental resources. Recent advances in artificial intelligence, particularly large language models (LLMs), have enabled virtual screening methods that reduce costs and improve efficiency. However, the growing complexity of these tools has limited their accessibility to wet-lab researchers. Multi-agent systems offer a promising solution by combining the interpretability of LLMs with the precision of specialized models and tools. In this work, we present MADD, a multi-agent system that builds and executes customized hit identification pipelines from natural language queries. MADD employs four coordinated agents to handle key subtasks in de novo compound generation and screening. We evaluate MADD across seven drug discovery cases and demonstrate its superior performance compared to existing LLM-based solutions. Using MADD, we pioneer the application of AI-first drug design to five biological targets and release the identified hit molecules. Finally, we introduce a new benchmark of query-molecule pairs and docking scores for over three million compounds to contribute to the agentic future of drug design.

cs.AI↗